Director of the Cambridge Stem Cell Institute.
Passionate about Blood Stem Cells | Single Cells | Developmental Biology | Healthy Ageing | Leukaemogenesis | Positive Research Culture
We have adapted the pipeline, but not yet published on it. I'd say that at this stage, it may be more useful to look at known enhancers rather than as a discovery tool.
We have adapted the pipeline, but not yet published on it. I'd say that at this stage, it may be more useful to look at known enhancers rather than as a discovery tool.